Jan 02, 2019
Luminex Corporation Completes Acquisition of MilliporeSigma's Flow Cytometry Portfolio
Dec 10, 2018
MilliporeSigma and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models
Nov 27, 2018
MilliporeSigma Wins Two R&D 100 Awards for Innovation in 2018
Nov 05, 2018
MilliporeSigma Launches BioContinuum(TM) Platform for Next-Generation Process Improvements
Oct 18, 2018
Luminex Corporation to Acquire MilliporeSigma's Flow Cytometry Portfolio
Aug 15, 2018
MilliporeSigma Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Technology
Jun 05, 2018
MilliporeSigma Brings Biotechs Closer to Drug Therapy Production and Commercialization
May 16, 2018
MilliporeSigma to Use Genome Editing in Study of Gut Bacteria to Benefit Malnourished Children
Apr 23, 2018
MilliporeSigma Receives Patent for CRISPR Technology in China
Apr 12, 2018
MilliporeSigma Helps Accelerate Global Access to Affordable Vaccines
Feb 20, 2018
MilliporeSigma Receives Two More Patents for CRISPR Technology
Feb 01, 2018
Merck KGaA, Darmstadt, Germany certified as one of the Top Employers North America 2018
Dec 20, 2017
MilliporeSigma Signs Commercial Supply Agreement with bluebird bio for Viral Vector Manufacturing
Dec 19, 2017
Singapore's IP Office to Grant MilliporeSigma's Patent Application for CRISPR Technology
Dec 11, 2017
MilliporeSigma Signs Distribution Agreement with Avanti® Polar Lipids
Nov 17, 2017
Merck KGaA, Darmstadt, Germany's Massachusetts-based Business Sectors Named 'Top Place to Work' by The Boston Globe
Nov 01, 2017
MilliporeSigma and Samsung BioLogics to Extend Strategic Alliance
Oct 19, 2017
MilliporeSigma Brings Customers Closer to Gene Therapy Product Commercialization
Oct 11, 2017
MilliporeSigma Opens New Life Science Center in Massachusetts for Scientific Collaboration
Oct 10, 2017
MilliporeSigma Presents 'Future Forum' at Boston's HUBweek 2017